Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook

About this update from Inspire Medical Systems, Inc.

[{"type":"image","alt":"Inspire Medical Systems","displaySize":"","headline":null,"caption":"Inspire Medical Systems","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/98bfab199b9d39d428b51783fc805b5d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/J27WasQA1o1J0GPVgccp_w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/98bfab199b9d39d428b51783fc805b5d","width":300,"height":95}},"lazy":false},{"type":"text","content":"MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2025.","length":356,"tagName":"p"},{"type":"text","content":"Recent Business Highlights","length":26,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Generated revenue of $224.5 million in the third quarter of 2025, a 10% increase over the same quarter last year","length":112,"tagName":"p"}]},{"val":[{"type":"text","content":"Achieved gross margin of 85.8% in the third quarter of 2025","length":59,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income was $9.9 million in the third quarter of 2025. Adjusted net income was $11.2 million","length":95,"tagName":"p"}]},{"val":[{"type":"text","content":"Income per share was $0.34 in the third quarter of 2025. Adjusted diluted earnings per share was $0.38","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Generated operating cash flow of $68.5 million for the third quarter of 2025, bringing the year-to-date total to $64.5 million","length":126,"tagName":"p"}]},{"val":[{"type":"text","content":"Presented Inspire V safety and efficacy data at recent industry meetings","length":72,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed $50 million in share repurchase","length":41,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":607,"olType":false},{"type":"text","content":"“The Inspire team had a very productive third quarter focusing on the transition to the Inspire V system while delivering very strong results globally,” said Tim Herbert, Chairman and Chi...

More updates from Inspire Medical Systems, Inc.